IL87590A - 2',3'-dihydrospiro(imidazolidine-4,4'-4'h-pyrano(2,3-b)pyridine)-2,5-diones and pharmaceutical compositions containing them - Google Patents

2',3'-dihydrospiro(imidazolidine-4,4'-4'h-pyrano(2,3-b)pyridine)-2,5-diones and pharmaceutical compositions containing them

Info

Publication number
IL87590A
IL87590A IL87590A IL8759088A IL87590A IL 87590 A IL87590 A IL 87590A IL 87590 A IL87590 A IL 87590A IL 8759088 A IL8759088 A IL 8759088A IL 87590 A IL87590 A IL 87590A
Authority
IL
Israel
Prior art keywords
dihydrospiro
pyrano
diones
imidazolidine
pyridine
Prior art date
Application number
IL87590A
Other languages
English (en)
Other versions
IL87590A0 (en
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IL87590A0 publication Critical patent/IL87590A0/xx
Publication of IL87590A publication Critical patent/IL87590A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/20Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Obesity (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
IL87590A 1987-09-04 1988-08-29 2',3'-dihydrospiro(imidazolidine-4,4'-4'h-pyrano(2,3-b)pyridine)-2,5-diones and pharmaceutical compositions containing them IL87590A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1987/002196 WO1989001775A1 (en) 1987-09-04 1987-09-04 Azolidinedione derivatives

Publications (2)

Publication Number Publication Date
IL87590A0 IL87590A0 (en) 1989-01-31
IL87590A true IL87590A (en) 1992-07-15

Family

ID=22202540

Family Applications (1)

Application Number Title Priority Date Filing Date
IL87590A IL87590A (en) 1987-09-04 1988-08-29 2',3'-dihydrospiro(imidazolidine-4,4'-4'h-pyrano(2,3-b)pyridine)-2,5-diones and pharmaceutical compositions containing them

Country Status (21)

Country Link
EP (1) EP0306251A3 (xx)
JP (1) JPS6471882A (xx)
KR (1) KR900008841B1 (xx)
CN (1) CN1022325C (xx)
AU (1) AU595467B2 (xx)
CS (1) CS273186B2 (xx)
DD (1) DD273381A5 (xx)
DK (1) DK488688A (xx)
EG (1) EG18591A (xx)
FI (1) FI901087A0 (xx)
HU (1) HU204832B (xx)
IL (1) IL87590A (xx)
MX (1) MX12896A (xx)
MY (1) MY103765A (xx)
NO (1) NO901016L (xx)
PH (1) PH24957A (xx)
PL (1) PL156798B1 (xx)
PT (1) PT88407B (xx)
WO (1) WO1989001775A1 (xx)
YU (1) YU46863B (xx)
ZA (1) ZA886507B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5068333A (en) * 1990-03-07 1991-11-26 Pfizer Inc. 6-chloro-3,4-dihydro-pyrano [2,3-b]pyridines having the R configuration
DE10210195B4 (de) 2002-03-07 2005-12-15 Schwarz Pharma Ag Verwendung von 1,3-Diazaspiro-[4,5]decan-2,4-dithion zur Behandlung von Schmerz
PT1873145E (pt) 2005-04-21 2012-12-03 Ishihara Sangyo Kaisha Método de produção de um derivado do ácido nicotínico ou de um seu sal

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1088945A (en) * 1976-10-18 1980-11-04 Pfizer Limited Hydantoin derivatives as therapeutic agents
US4176185A (en) * 1979-01-22 1979-11-27 Pfizer Inc. Spiro-quinolylhydantoins
US4226875A (en) * 1979-04-02 1980-10-07 Pfizer Inc. Novel spiro-oxazolidinediones
FR2455046A1 (fr) * 1979-04-25 1980-11-21 Science Union & Cie Nouvelles hydantoines, leur procede de preparation et leur emploi comme medicament
US4235911A (en) * 1979-06-13 1980-11-25 Pfizer Inc. Hydantoin derivatives
US4248882A (en) * 1980-02-12 1981-02-03 Pfizer Inc. Treating diabetes-associated complications with hydantoin amines
DE3262294D1 (en) * 1981-05-13 1985-03-28 Ici Plc Pharmaceutical compositions containing spiro succinimide derivatives

Also Published As

Publication number Publication date
CS273186B2 (en) 1991-03-12
MX12896A (es) 1993-06-01
PL274504A1 (en) 1989-05-02
JPS6471882A (en) 1989-03-16
HU204832B (en) 1992-02-28
JPH0583554B2 (xx) 1993-11-26
CS591188A2 (en) 1990-06-13
EP0306251A3 (en) 1990-08-01
AU2184188A (en) 1989-03-09
IL87590A0 (en) 1989-01-31
KR900008841B1 (ko) 1990-11-30
PT88407B (pt) 1992-10-30
CN1022325C (zh) 1993-10-06
NO901016D0 (no) 1990-03-02
PT88407A (pt) 1989-07-31
WO1989001775A1 (en) 1989-03-09
MY103765A (en) 1993-09-30
HUT56106A (en) 1991-07-29
NO901016L (no) 1990-05-02
AU595467B2 (en) 1990-03-29
YU46863B (sh) 1994-06-24
FI901087A0 (fi) 1990-03-02
PL156798B1 (pl) 1992-04-30
CN1031702A (zh) 1989-03-15
DK488688D0 (da) 1988-09-02
EP0306251A2 (en) 1989-03-08
DD273381A5 (de) 1989-11-15
KR890005112A (ko) 1989-05-11
DK488688A (da) 1989-04-07
YU167788A (en) 1990-06-30
ZA886507B (en) 1990-04-25
PH24957A (en) 1990-12-26
EG18591A (en) 1993-06-30

Similar Documents

Publication Publication Date Title
IL81611A (en) N-cycloalkano(1,2-b)indole derivatives of aryl-sulfonamides,their preparation and medicaments containing them
AU5845786A (en) Pyrano(3,2-C) pyridine derivatives
IL89347A0 (en) Thieno(3,2-b)pyridines,process for their preparation and pharmaceutical compositions containing them
IL75197A (en) 3-(tetralinaminoalkyl)benzazepine and 1,3-benzodiazepine derivatives,their preparation and pharmaceutical compositions containing them
IL92791A0 (en) Annelated indolo(3,2-c)lactams,their preparation and pharmaceutical compositions containing them
IL81209A (en) Substituted 6h-indolo(2,3-b)-quinoxalines,their preparation and pharmaceutical compositions comprising them
NZ227833A (en) 2,5-dioxo-hexahydro pyrrollo-imidazole and octahydro imidazo pyridine (and azepine) derivatives: preparation, intermediates and pharmaceutical compositions thereof
IL94883A0 (en) 5,11-dihydro-6h-dihydro(3,2-b:2',3'-e)(1,4)diazepin-6-ones and-thiones,their preparation and pharmaceutical compositions containing them
IL93136A0 (en) Tetrahydroimidazo(1,4)benzodiazepin-2-thione derivatives,their preparation and pharmaceutical compositions containing them
IL75135A (en) Hexa-and tetrahydrobenzo(thio)pyrano(3,4-b)pyridines,their preparation and pharmaceutical compositions containing them
IL54813A0 (en) Novel pyrido(2,3-b) (1,4) benzodiazepine derivatives, their preparation and pharmaceutical compositions containing
GB9109810D0 (en) Preparation of non-racemic furo(3,4-c)pyridine derivatives
IL81602A0 (en) Substituted 1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acids,their preparation and pharmaceutical compositions containing them
IL90046A0 (en) 6-aryl-substituted-4h-thieno(2,3-e)(1,2,4)triazolo-(3,4-c)(1,4)diazepines,their preparation and pharmaceutical compositions containing them
IL89459A0 (en) 4-substituted pyrazolo(3,4-d)pyrimidine derivatives,their preparation and pharmaceutical compositions containing them
IL54814A0 (en) Novel pyrido(2,3-b) (1,4) benzodiazepine derivatives, their preparation and pharmaceutical compositions containing tthem
NZ218207A (en) Hexahydro-(1)-benzo(pyrano and thiopyrano)(4,3-c)- pyridines and pharmaceutical compositions
IL86888A0 (en) 3',4'-dinitrogen substituted epipodophyllotoxin glucoside derivatives and pharmaceutical compositions containing them
IL87590A (en) 2',3'-dihydrospiro(imidazolidine-4,4'-4'h-pyrano(2,3-b)pyridine)-2,5-diones and pharmaceutical compositions containing them
IL76619A0 (en) Thieno-and furo(2,3-c)pyrrole derivatives,their preparation and pharmaceutical compositions containing them
IL83101A0 (en) Substituted hexahydro arylquinolizines,their preparation and pharmaceutical compositions containing them
AU7827887A (en) Spiro derivatives
IL85187A (en) Tetrahydro-methylcycloalka(1,2-c:4,3-c)dipyrazoles,their preparation and pharmaceutical compositions containing them
IL89098A (en) Amino- or cyclicamino-acyl substituted pyrido-(2,3-b) (1,4)-and thieno (3,4-b) (1,5) benzodiazepinones, their preparation and pharmaceutical compositions containing them
NZ219403A (en) 1,3,4,9-tetrahydropyrano(3,4-b indole-1-acetic acid derivatives and pharmaceutical compositions